Hakan Timur1, Nafiye Yimaz2, Inci Kahyaoglu3, Hasan Ali Inal4, Salim Erkaya2. 1. Department of Reproductive Endocrinology, Dr. Zekai Tahir Burak Women's Health Education and Research Hospital, ZTB, Hamaonu, Altindag, 06500, Ankara, Turkey. drhakantimur@gmail.com. 2. Department of Reproductive Endocrinology, Dr. Zekai Tahir Burak Women's Health Education and Research Hospital, ZTB, Hamaonu, Altindag, 06500, Ankara, Turkey. 3. Department of Reproductive Endocrinology, Etlik Zubeyde Hanim Women's Health Education and Research Hospital, Ankara, Turkey. 4. Department of Obstetrics and Gynecology, Konya Education and Research Hospital, Konya, Turkey.
Abstract
PURPOSE: In this study, we aimed to investigate serum and follicular fluid amyloid A protein levels in non-obese non-hyperandrogenic patients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) and IVF outcome. METHODS: A total of 81 patients undergoing IVF treatment, 41 patients diagnosed as PCOS according to the Rotterdam criteria (group I) and 40 patients with the etiology of male factor infertility (group II), were included in the study. On the day of oocyte pickup, serum and follicular fluid samples were collected from all patients. RESULTS: Serum E2 level on the day of hCG (2849.93 ± 541.54 vs. 2494.28 ± 712.98) and total number of retrieved oocytes (13.73 ± 3.57 vs. 10.53 ± 4.07) were significantly higher in group I when compared to group II (p < 0.05). However, number of mature oocytes, fertilization rate, and clinical pregnancy rate did not differ (p > 0.05). No significant difference was found between two groups regarding the serum and follicular fluid amyloid A protein levels on the day of oocyte retrieval (p > 0.05).
PURPOSE: In this study, we aimed to investigate serum and follicular fluid amyloid A protein levels in non-obese non-hyperandrogenicpatients with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) and IVF outcome. METHODS: A total of 81 patients undergoing IVF treatment, 41 patients diagnosed as PCOS according to the Rotterdam criteria (group I) and 40 patients with the etiology of male factor infertility (group II), were included in the study. On the day of oocyte pickup, serum and follicular fluid samples were collected from all patients. RESULTS: Serum E2 level on the day of hCG (2849.93 ± 541.54 vs. 2494.28 ± 712.98) and total number of retrieved oocytes (13.73 ± 3.57 vs. 10.53 ± 4.07) were significantly higher in group I when compared to group II (p < 0.05). However, number of mature oocytes, fertilization rate, and clinical pregnancy rate did not differ (p > 0.05). No significant difference was found between two groups regarding the serum and follicular fluid amyloid A protein levels on the day of oocyte retrieval (p > 0.05).
Entities:
Keywords:
Adipokine; Amyloid A; In vitro fertilization; Polycystic ovary syndrome
Authors: Margareta Jernås; Jenny Palming; Kajsa Sjöholm; Eva Jennische; Per-Arne Svensson; Britt G Gabrielsson; Max Levin; Anders Sjögren; Mats Rudemo; Theodore C Lystig; Björn Carlsson; Lena M S Carlsson; Malin Lönn Journal: FASEB J Date: 2006-06-05 Impact factor: 5.191
Authors: Kajsa Sjöholm; Jenny Palming; Louise E Olofsson; Anders Gummesson; Per-Arne Svensson; Theodore C Lystig; Eva Jennische; John Brandberg; Jarl S Torgerson; Björn Carlsson; Lena M S Carlsson Journal: J Clin Endocrinol Metab Date: 2004-12-28 Impact factor: 5.958
Authors: S H Yap; H J Moshage; B P Hazenberg; H M Roelofs; J Bijzet; P C Limburg; L A Aarden; M H van Rijswijk Journal: Biochim Biophys Acta Date: 1991-02-19
Authors: Rong-Ze Yang; Mi-Jeong Lee; Hong Hu; Toni I Pollin; Alice S Ryan; Barbara J Nicklas; Soren Snitker; Richard B Horenstein; Kristen Hull; Nelson H Goldberg; Andrew P Goldberg; Alan R Shuldiner; Susan K Fried; Da-Wei Gong Journal: PLoS Med Date: 2006-06 Impact factor: 11.069